Kymera Therapeutics, Inc. (KYMR)
USD 39.06
(-7.66%)
USD 39.06
(-7.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 78.59 Million | 46.82 Million | 72.83 Million | 34.03 Million | 2.93 Million | - |
| Cost of Revenue | 189.08 Million | 2.97 Million | 2.39 Million | 62.1 Million | 825 Thousand | 205 Thousand |
| Gross Profit | -110.48 Million | 43.84 Million | 70.43 Million | -28.07 Million | 2.1 Million | -205 Thousand |
| Operating Expenses | 244.12 Million | 208.08 Million | 173.36 Million | 80.33 Million | 45.13 Million | 21.45 Million |
| Selling, General and Administrative Expenses | 55.04 Million | 43.83 Million | 36.34 Million | 18.23 Million | 7.98 Million | 3.77 Million |
| Research and Development Expenses | 189.08 Million | 164.24 Million | 137.01 Million | 62.1 Million | 37.15 Million | 17.67 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 244.12 Million | 208.08 Million | 173.36 Million | 80.33 Million | 45.13 Million | 21.45 Million |
| Operating Income | -165.53 Million | -161.25 Million | -100.53 Million | -46.3 Million | -42.2 Million | -21.45 Million |
| Interest Expense | 196 Thousand | 176 Thousand | 175 Thousand | 115 Thousand | 46 Thousand | 16 Thousand |
| Income Tax Expense | - | -2.97 Million | -2.22 Million | -1.64 Million | 46 Thousand | 43.85 Thousand |
| Earnings before Tax | -146.96 Million | -154.8 Million | -100.21 Million | -45.59 Million | -41.24 Million | -21.46 Million |
| Net Income | -146.96 Million | -151.83 Million | -97.99 Million | -43.94 Million | -41.29 Million | -21.46 Million |
| Earnings Per Share Basic | -2.52 | -2.82 | -2.04 | -2.53 | -0.93 | -0.48 |
| Earnings Per Share Diluted | -2.52 | -2.82 | -2.04 | -2.53 | -0.93 | -0.48 |
| Weighted Average Shares Outstanding | 58.36 Million | 53.93 Million | 47.98 Million | 17.34 Million | 44.52 Million | 44.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 58.36 Million | 53.93 Million | 47.98 Million | 17.34 Million | 44.52 Million | 44.52 Million |
| Gross Margin | -1.41 | 0.94 | 0.97 | -0.82 | 0.72 | - |
| EBIT Margin | -1.82 | -3.30 | -1.37 | -1.34 | -13.76 | - |
| Profit Margin | -1.87 | -3.24 | -1.35 | -1.29 | -14.07 | - |
| EBITDA | -143.2 Million | -151.65 Million | -97.64 Million | -43.71 Million | -40.37 Million | -21.24 Million |
| Earnings Before Tax Margin | -2.11 | -3.44 | -1.38 | -1.36 | -14.38 | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 3.74 Million | 25.65 Million | 10.28 Million | 47.88 Million | 78.59 Million | 4.72 Million |
| Cost of Revenue | 2 Million | 1.9 Million | 1.5 Million | 865 Thousand | 3.56 Million | 900 Thousand |
| Gross Profit | 1.74 Million | 23.75 Million | 8.78 Million | 47.02 Million | 75.02 Million | 3.82 Million |
| Operating Expenses | 75.86 Million | 74.67 Million | 61.69 Million | 67.19 Million | 244.12 Million | 62.23 Million |
| Selling, General and Administrative Expenses | 15.45 Million | 17.37 Million | 14.37 Million | 14.22 Million | - | 14.12 Million |
| Research and Development Expenses | 60.41 Million | 57.3 Million | 48.81 Million | 52.97 Million | - | 48.11 Million |
| Other Expenses | - | - | -47.31 Million | - | - | - |
| Cost and Expenses | 75.86 Million | 76.57 Million | 63.19 Million | 67.19 Million | 244.12 Million | 62.23 Million |
| Operating Income | -72.12 Million | -50.92 Million | -52.9 Million | -19.31 Million | -165.53 Million | -57.5 Million |
| Interest Expense | -60 Thousand | 61 Thousand | 69 Thousand | 52 Thousand | 196 Thousand | -41 Thousand |
| Income Tax Expense | -2 Million | - | 39 Thousand | 4.99 Million | 18.76 Million | -895 Thousand |
| Earnings before Tax | -62.48 Million | -42.06 Million | -48.55 Million | -14.36 Million | -146.96 Million | -52.86 Million |
| Net Income | -62.48 Million | -42.06 Million | -48.55 Million | -14.36 Million | -146.96 Million | -52.86 Million |
| Earnings Per Share Basic | -0.82 | -0.58 | -0.69 | -0.25 | - | -0.90 |
| Earnings Per Share Diluted | -0.82 | -0.58 | -0.69 | -0.25 | - | -0.90 |
| Weighted Average Shares Outstanding | 76.12 Million | 73.05 Million | 70.77 Million | 58.52 Million | 58.36 Million | 58.42 Million |
| Weighted Average Shares Outstanding (Diluted) | 76.12 Million | 73.05 Million | 70.77 Million | 58.52 Million | 58.36 Million | 58.42 Million |
| Gross Margin | 0.47 | 0.93 | 0.85 | 0.98 | 0.95 | 0.81 |
| EBIT Margin | -19.28 | -1.91 | -5.00 | -0.28 | - | -12.16 |
| Profit Margin | -16.70 | -1.64 | -4.72 | -0.30 | -1.87 | -11.18 |
| EBITDA | -72.12 Million | -49.02 Million | -51.4 Million | -13.42 Million | - | -57.5 Million |
| Earnings Before Tax Margin | -19.28 | -1.99 | -5.14 | -0.40 | -2.11 | -12.16 |
GPW
FE
6923
3138
NTFL
SREI